56 filings
Page 2 of 3
8-K
s1kco142fjvf72 iag
2 May 23
Departure of Directors or Certain Officers
7:37am
8-K
khig0yte35
23 Mar 23
Invivyd Reports Full Year 2022 Financial Results and Business Highlights
4:12pm
8-K
2jvt68w
6 Mar 23
Invivyd Optimizes Development Efficiency with Election of VYD222 for Near-term Clinical
7:42am
8-K
8sfd32 ij
9 Jan 23
Other Events
7:11am
8-K
v90s8w1t
6 Dec 22
Departure of Directors or Certain Officers
4:28pm
8-K
c9vj5 tqf6jgtvn
17 Nov 22
Invivyd Announces Partnership with Population Health Partners to Accelerate Clinical Development In Infectious Diseases Including COVID-19
7:10am
8-K
8tbq3cm m9bdk6mbwv5b
10 Nov 22
Invivyd Reports Third Quarter 2022 Financial Results and Business Highlights
4:13pm
8-K
5peo1 tro0dtk4c6
24 Oct 22
Invivyd Announces the Appointment of Christine Lindenboom to Board of Directors
4:30pm
8-K
qlwfygq4tht0
13 Oct 22
Invivyd Appoints Fred Driscoll as Interim Chief Financial Officer and Announces Resource Reallocation to Maximize Integrated Discovery
4:16pm
8-K
tq9y qt6icei
13 Sep 22
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
7vy8vyuvylidcc d9j
12 Sep 22
Adagio Therapeutics Announces Corporate Name Change to Invivyd
7:46am
8-K
jzy3t
15 Aug 22
Adagio Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights
7:22am
8-K
lfjvvta8rc7 hbx
5 Jul 22
Adagio Announces Results of Annual Meeting of Stockholders and Evolution of the Board of Directors
4:41pm
8-K
7c4jx e6ez
30 Jun 22
Departure of Directors or Certain Officers
4:30pm
8-K
f9esc8h gcvyvztfi5t0
22 Jun 22
Submission of Matters to a Vote of Security Holders
5:18pm
8-K
dbuccx29xhvizfe0wtn
21 Jun 22
Departure of Directors or Certain Officers
5:17pm
8-K
m3pom4v
19 May 22
Other Events
5:14pm
8-K
xj0pck1ya
13 May 22
Adagio Therapeutics Reports First Quarter 2022 Financial Results
7:00am
8-K
9j7anhm
30 Mar 22
Results of Operations and Financial Condition
7:40am
8-K
zty22
21 Mar 22
Departure of Directors or Certain Officers
6:32am